Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stephens

Showing results (931-940 of 1,072) with videos related to

Pageof 108
Sort By:
Implementation Science : IS|June 16, 2021
Handoffs and transitions in critical care-understanding scalability: study protocol for a multicenter stepped wedge type 2 hybrid effectiveness-implementation trialMeghan B Lane-Fall, Athena Christakos, Gina C Russell, et al.
British Journal of Cancer|April 21, 2018
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinomaGuillermo de Velasco, Stephanie A Wankowicz, Russell Madison, et al.
Oncotarget|June 15, 2018
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profilingKatherine Tarlock, Shan Zhong, Yuting He, et al.
Medical Physics|May 16, 2019
Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CTJohanna Uthoff, Matthew J Stephens, John D Newell, et al.
Lancet (London, England)|March 27, 2010
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data, R Arriagada, A Auperin, et al.
Cell Reports|May 13, 2014
Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, et al.
Breast Cancer Research and Treatment|February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breastSahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
British Journal of Pharmacology|March 23, 2024
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in reviewAndreas Papapetropoulos, Stavros Topouzis, Steve P H Alexander, et al.
British Journal of Pharmacology|August 11, 2024
Natural product pharmacology: the British Journal of Pharmacology perspectiveXin Wang, Angelo A Izzo, Andreas Papapetropoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research CouncilM T Seymour, M L Slevin, D J Kerr, et al.
Pageof 108

Showing results (931-940 of 1,072) with videos related to

Sort By:
Pageof 108
Implementation Science : IS|June 16, 2021
Handoffs and transitions in critical care-understanding scalability: study protocol for a multicenter stepped wedge type 2 hybrid effectiveness-implementation trialMeghan B Lane-Fall, Athena Christakos, Gina C Russell, et al.
British Journal of Cancer|April 21, 2018
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinomaGuillermo de Velasco, Stephanie A Wankowicz, Russell Madison, et al.
Oncotarget|June 15, 2018
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profilingKatherine Tarlock, Shan Zhong, Yuting He, et al.
Medical Physics|May 16, 2019
Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CTJohanna Uthoff, Matthew J Stephens, John D Newell, et al.
Lancet (London, England)|March 27, 2010
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data, R Arriagada, A Auperin, et al.
Cell Reports|May 13, 2014
Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, et al.
Breast Cancer Research and Treatment|February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breastSahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
British Journal of Pharmacology|March 23, 2024
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in reviewAndreas Papapetropoulos, Stavros Topouzis, Steve P H Alexander, et al.
British Journal of Pharmacology|August 11, 2024
Natural product pharmacology: the British Journal of Pharmacology perspectiveXin Wang, Angelo A Izzo, Andreas Papapetropoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research CouncilM T Seymour, M L Slevin, D J Kerr, et al.
Pageof 108